Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Kristin K. Zorn(University of Pittsburgh), Michael J. Birrer(University of Arkansas Medical Center), Jeff Boyd(Northwell Health), Samuel C. Mok(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Ginger J. Gardner(Memorial Sloan Kettering Cancer Center), Christopher S. Awtrey(Breast Cancer Research Foundation)
PubMed
October 15, 2003
Cited by 101
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
|Nature Communications|2016|785